Molecular analysis of prognostically significant markers of chronic lymphocytic leukemia
Mgr. Erika Tomková, RNDr. Miroslav Tomka, PhD., RNDr. Renáta Lukačková, Mgr. Jakub Petrík
Chronic lymphocytic leukemia (CLL) is a clinically and biologically substantially heterogenous disease. In general, patients are classified into two groups: patients with indolent disease form...
RNDr. Tomáš Szemes, PhD., RNDr. Gabriel Minárik, PhD., RNDr. Michaela Hýblová, MUDr. Jana Barošová, Werner Krampl
Non-invasive prenatal testing (NIPT) of the most frequent aneuploidies by way of analysing the free DNA obtained from peripheral blood of pregnant women represents on...
Cytogenetic and molecular changes in myelodysplastic syndromes
RNDr. Renáta Lukačková, Mgr. Jakub Petrík, Mgr. Kristína Juríková
Myelodysplastic syndromes (MDS) consist of hematologic diseases which differ in clinical features and also in cytogenetic presentation. They are characterized with abnormal development of at...
